| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0007 | 1 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.00062 | 1 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.00046 | 1 |